BioCentury | Dec 8, 2020
Deals

Dec. 7 Quick Takes: Sino pays $515M for Sinovac stake; plus BioCryst, Roivant, AbCellera, Syros, YZY, Maze

...for limited royalty rights to sales of Orladeyo berotralstat, and $200 million in credit from Athyrium Capital Management...
BioCentury | May 29, 2020
Finance

May 28 Quick Takes: Illumina leads $70M Ginkgo round; plus Arena, Viela Bio, BioCryst, Progenity and Microbion

...listing Progenity Inc. filed to raise up to $100 million in an IPO on NASDAQ. Athyrium Capital Management...
BioCentury | Oct 5, 2018
Financial News

Kala raises $61.9M follow-on

...the offering after market hours. On Oct. 2, Kala secured a $75 million loan from Athyrium Capital Management...
BioCentury | Oct 3, 2018
Financial News

GW, Epizyme, Kala price follow-ons

...Cantor Fitzgerald, Wedbush PacGrow and Oppenheimer. On Tuesday, Kala secured a $75 million loan from Athyrium Capital Management...
BioCentury | Jan 5, 2018
Financial News

OptiNose draws down $75M in debt financing

...Inc. (NASDAQ:OPTN) said on Jan. 2 it entered a $100 million debt financing agreement with Athyrium Capital Management...
BioCentury | Dec 2, 2017
Financial News

Athyrium, Neuberger close $2B third fund

Athyrium Capital Management and Neuberger Berman closed Athyrium Opportunities Fund III at $2.025 billion. The new fund will make investments in commercial-stage companies across the healthcare ecosystem, with more than 50% of the capital expected...
BioCentury | Dec 2, 2017
Finance

Opportunity sizing

...support from existing and new LPs and an attractively priced healthcare sector to play in, Athyrium Capital Management...
BioCentury | May 9, 2016
Financial News

Relypsa completes debt financing

...Date completed: 2016-05-03 Type: Debt financing Raised: $150 million Shares outstanding prior: 44.7 million Investors: Athyrium Capital Management...
BioCentury | May 5, 2016
Financial News

Relypsa sinks after debt financing

...19%) to $14 on Wednesday after it closed a $150 million debt offering underwritten by Athyrium Capital Management...
BioCentury | Feb 1, 2016
Financial News

Halozyme completes debt financing

...Endocrine/Metabolic, Cancer, Dermatology Date completed: 2016-01-26 Type: Debt financing Raised: $150 million Investors: Pharmakon Advisors; Athyrium Capital Management...
Items per page:
1 - 10 of 22
BioCentury | Dec 8, 2020
Deals

Dec. 7 Quick Takes: Sino pays $515M for Sinovac stake; plus BioCryst, Roivant, AbCellera, Syros, YZY, Maze

...for limited royalty rights to sales of Orladeyo berotralstat, and $200 million in credit from Athyrium Capital Management...
BioCentury | May 29, 2020
Finance

May 28 Quick Takes: Illumina leads $70M Ginkgo round; plus Arena, Viela Bio, BioCryst, Progenity and Microbion

...listing Progenity Inc. filed to raise up to $100 million in an IPO on NASDAQ. Athyrium Capital Management...
BioCentury | Oct 5, 2018
Financial News

Kala raises $61.9M follow-on

...the offering after market hours. On Oct. 2, Kala secured a $75 million loan from Athyrium Capital Management...
BioCentury | Oct 3, 2018
Financial News

GW, Epizyme, Kala price follow-ons

...Cantor Fitzgerald, Wedbush PacGrow and Oppenheimer. On Tuesday, Kala secured a $75 million loan from Athyrium Capital Management...
BioCentury | Jan 5, 2018
Financial News

OptiNose draws down $75M in debt financing

...Inc. (NASDAQ:OPTN) said on Jan. 2 it entered a $100 million debt financing agreement with Athyrium Capital Management...
BioCentury | Dec 2, 2017
Financial News

Athyrium, Neuberger close $2B third fund

Athyrium Capital Management and Neuberger Berman closed Athyrium Opportunities Fund III at $2.025 billion. The new fund will make investments in commercial-stage companies across the healthcare ecosystem, with more than 50% of the capital expected...
BioCentury | Dec 2, 2017
Finance

Opportunity sizing

...support from existing and new LPs and an attractively priced healthcare sector to play in, Athyrium Capital Management...
BioCentury | May 9, 2016
Financial News

Relypsa completes debt financing

...Date completed: 2016-05-03 Type: Debt financing Raised: $150 million Shares outstanding prior: 44.7 million Investors: Athyrium Capital Management...
BioCentury | May 5, 2016
Financial News

Relypsa sinks after debt financing

...19%) to $14 on Wednesday after it closed a $150 million debt offering underwritten by Athyrium Capital Management...
BioCentury | Feb 1, 2016
Financial News

Halozyme completes debt financing

...Endocrine/Metabolic, Cancer, Dermatology Date completed: 2016-01-26 Type: Debt financing Raised: $150 million Investors: Pharmakon Advisors; Athyrium Capital Management...
Items per page:
1 - 10 of 22